March 5, 2026: FDA Issues Warning Letter to Novo Nordisk About Reporting Adverse Events for its GLP-1s The FDAs Center for Drug Evaluation and Research (CDER) has issued a warning letter to Novo Nordisk, Ozempics maker
Heartburn is a symptom, acid reflux is the event of stomach contents moving upward, and GERD is the chronic condition when those events are frequent enough to cause ongoing damage or regular symptoms
Analyses from STEP-HFpEF (Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
In women, obesity can increase the severity of menopause symptoms
Comparison of GLP-1 Receptor Agonists, SGLT-2 Inhibitors, and DPP-4 Inhibitors as Add-On to Insulin: Umbrella Review
Reconstituted solutions should be stored at 2 to 8 degrees Celsius